Public Calendar: April 20 - 26, 2025
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs
Event Date: 04/24/2025
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: GRACE GRAHAM;
Non FDA Participant/Group: Senator Rick Scott (R-FL)
Event Date: 04/24/2025
Location: Washington, DC
Subject: 2025 Semafor World Economy Summit; Speaker: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees
Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
No Significant Event
Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 04/23/2025
Location: Silver Spring, MD
Subject: Infant Formula/Operations Storkspeed Matters of Mutual Interest
FDA Participant/Group: REBECCA BUCKNER; ROBIN MCKINNON; DAYLE CRISTINZIO; DONALD PRATER;
Non FDA Participant/Group: Zac Omar (PediaGROW);
Official Name: Kyle Diamantas, J.D., Acting Deputy Commissioner for Human Foods
Event Date: 04/25/2025
Location: College Park, MD
Subject: Dietary Supplements
FDA Participant/Group: LARRY MORRIS; MARK HARTMAN; CARA WELCH;
Non FDA Participant/Group: Andrea Wong, Jeff Ventura , Julia Gustafson, Megan Olsen, Steve Mister (Council for Responsible Nutrition);
Event Date: 04/25/2025
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: De Ann Davis, Gustavo Reyes, Joelle Mosso, Jonathan Sarager, Sonia Salas (Western Growers);
Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event
Official Name: Lowell Zeta, Deputy Commissioner for Strategic Initiatives
No Significant Event
Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Scott Steele, Ph.D., Acting Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research
Event Date: 04/23/2025
Location: Washington, DC
Subject: Duke Clinical Research Institute (DCRI) Think Tank: The First and Last Mile: Primary Care; Panelist: Use Cases of Trials in Primary Care Settings that Bring Value to Stakeholders
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and academia
Official Name: Timothy Schell, Acting Director, Center for Veterinary Medicine
No Significant Event